공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 커넥티드 헬스케어 시장 예측

Connected Healthcare Market Research Report - Global Forecast to 2022

리서치사 Market Research Future
발행일 2016년 12월 상품 코드 512211
페이지 정보 영문 148 Pages
가격
US $ 4,450 ₩ 5,029,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,064,000 Printable PDF (Corporate User License)


세계의 커넥티드 헬스케어 시장 예측 Connected Healthcare Market Research Report - Global Forecast to 2022
발행일 : 2016년 12월 페이지 정보 : 영문 148 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 커넥티드 헬스케어 시장에 대해 조사했으며, 종류·용도·지역별 시장 동향, 매출 예측, 시장 촉진·저해요인, 시장 기회, 시장 점유율 분석, 시장 전망, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 서문

제2장 서론

제3장 조사 방법

제4장 시장 역학

  • 서론
  • 시장 성장 촉진요인
  • 시장 성장 저해요인
  • 시장 기회
  • 시장이 해결해야 할 과제

제5장 시장 분석

  • Porter의 산업 분석
  • 밸류체인 분석

제6장 세계의 커넥티드 헬스케어 시장 : 종류별

  • 서론
  • 모바일 헬스 서비스
    • 모바일 헬스 앱 & 컨텐츠 솔루션
      • 소프트웨어
      • 빅데이터
    • 네트워크 & 서비스/모바일 사업자
    • 의료 제공자 & 제약기업
  • 모바일 헬스 디바이스
    • 의료기기
      • 자가혈당측정기(SMBG)
      • 혈당 모니터
      • 심전계
      • 펄스옥시미터
      • 기타
    • 웨어러블 디바이스
      • 장갑형 디바이스
      • 두부 장착형 디바이스
      • 신체 장착형 디바이스
  • 온라인 처방전

제7장 세계의 커넥티드 헬스케어 시장 : 용도별

  • 서론
  • 모니터링
  • 진단·치료
  • 교육
  • 의료 관리
  • 건강·예방
  • 기타

제8장 세계의 커넥티드 헬스케어 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 중동·아프리카

제9장 경쟁 구도

  • 서론
    • 사업 제휴·합의
    • 제품 개발·발표
    • 승인
    • 인수
    • 수상력·평가
    • 기타

제10장 기업 개요

  • Agamatrix, Inc.
  • AirStrip Technologies
  • AliveCor Inc.
  • Allscripts
  • Apple Inc.
  • Athenahealth, Inc.
  • Boston Scientific Corporation
  • Cerner
  • GE Healthcare
  • Honeywell Life Care Solutions
  • Medtronics
  • Microsoft
  • Persistent Systems
  • Koninklijke Philips N.V.
  • Qualcomm
  • Sanofi
  • Vivify Health, inc.

제11장 부록

KSA 17.06.26

Introduction

Connected healthcare solutions consolidate information from many different spheres of a person's world to give a more complete picture of their health that includes biological, genetic, medical, lifestyle and sentiment/mood data. These solutions puts the patient at the centre of the healthcare system gathering, linking and interpreting information from many different sources to enable informed, patient-centred care decisions.

Global Connected Healthcare market has been segmented on the basis of type which comprises of M-health devices, M-health services and E-prescription. On the basis of application; market is segmented into Monitoring Applications, Diagnosis & Treatment, Education and Awareness, Healthcare Management, Wellness & Prevention and others.

The global Connected Healthcare market was around USD 16.54 billion in 2016 and is expected to reach USD 105.33 billion at the rate of about 30.27 % from 2016 to 2022.

Key Players

The key players profiled in the research report : Agamatrix, Inc. (US), Airstrip Technology (US), AliveCor Inc. (Australia), Allscripts (US), Athenahealth Inc. (US), Boston Scientific Corporation (US), Cerner (US), Koninklijke Philips N.V. (Netherlands), GE healthcare (UK), Qualcomm (US), Medtronics (Ireland) and others..

Study Objectives:

  • To provide insights about factors, influencing and affecting the market growth.
  • To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
  • To provide historical and forecast revenue of the market segments based on type, application, and others.
  • To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.

Target Audience

  • Medical device manufacturers
  • Medical device suppliers
  • Government Research Laboratory
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories

Key Findings

  • The global Connected Healthcare market and is expected to reach US 105.33 billion by 2022.
  • Regionally, North America holds the largest market share for global Connected Healthcare market and is expected to grow at a CAGR of 28.75% by 2022.
  • Asia Pacific market is expected to be the fastest growing market, and expected to reach at USD 24.07 billion by 2022.
  • On the basis of type, M-health services segment holds largest market share.

The reports also cover country level analysis:

America

  • North America

Europe

Western Europe

  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Rest of Western Europe
  • Eastern Europe

Asia

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia

Middle East & Africa

Table of Contents

1. Report Prologue

2. Introduction

  • 2.1. Scope of Study
  • 2.2. Research Objective
  • 2.3. Assumptions & Limitations
    • 2.3.1. Assumptions
    • 2.3.2. Limitations
  • 2.4. Market Structure

3. Research Methodology

  • 3.1. Research Process
  • 3.2. Primary Research
  • 3.3. Secondary Research

4. Market Dynamics

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Connected Healthcare applications has increased the involvement of patient population
    • 4.2.2. Increasing use of Smartphones and wearable devices into healthcare has led to the growth of the market
    • 4.2.3. Cost effectiveness and Patients' Convenience will drive the connected healthcare market
    • 4.2.4. Continuous increase in Lifestyle Disease has led to the development of personalized healthcare solutions
  • 4.3. Restraints
    • 4.3.1. Increasing privacy and cybercrimes restraint the growth of connected healthcare market
    • 4.3.2. Lack of Awareness about the possible applications of connected healthcare
    • 4.3.3. Reluctance to share information regarding the health has limit the growth of the market
  • 4.4. Opportunities
    • 4.4.1. Growing partnership between the companies has become the entrance gateway for new firms
    • 4.4.2. Introduction of connected healthcare in developing economies will boost the growth of the connected healthcare
  • 4.5. Challenges
    • 4.5.1. Low rate of literacy and language barriers in low- and middle-income countries (LMICs) is a big challenge for the connected healthcare solutions
    • 4.5.2. Potential risk of Hardware or Software failure will barred the growth of the market
    • 4.5.3. Stringent Regulations and Standards will restraining the growth of the market

5. Market Factor Analysis

  • 5.1. Connected Healthcare Device: Porter's Five Force Analysis
    • 5.1.1. Bargaining Power of Buyer
    • 5.1.2. Bargaining Power of Supplier
    • 5.1.3. Threat from substitute
    • 5.1.4. Threat from a New Entrant
    • 5.1.5. Intensity of Competitive Rivalry
  • 5.2. Value Chain Analysis
    • 5.2.1. Device Manufacturers
    • 5.2.2. App Developers
    • 5.2.3. Network providers/ Mobile operators
    • 5.2.4. Healthcare providers and Pharmaceuticals
    • 5.2.5. Patients

6. Connected Healthcare Market, By Types

  • 6.1. Introduction
  • 6.2. M-Health Services
    • 6.2.1. Mobile health Apps and Content Solution
      • 6.2.1.1. Software
      • 6.2.1.2. Big Data
    • 6.2.2. Network and Services/ Mobile operators
    • 6.2.3. Healthcare Providers and Pharmaceuticals
      • 6.2.3.1. Healthcare providers
      • 6.2.3.2. Pharmaceuticals
  • 6.3. M-Health Devices
    • 6.3.1. Medical Devices
      • 6.3.1.1. SMBG
      • 6.3.1.2. Blood Pressure Monitor
      • 6.3.1.3. Cardiac Monitors
      • 6.3.1.4. Pulse Oximeter
      • 6.3.1.5. Other Medical Devices
    • 6.3.2. Wearable Devices
      • 6.3.2.1. Hand Worn Products
      • 6.3.2.1.1. Smart Watch
      • 6.3.2.1.2. Wrist Wear
      • 6.3.2.2. Head Worn Products
      • 6.3.2.2.1. AR/VR HMD/HUD
      • 6.3.2.2.2. Others
      • 6.3.2.3. Body worn products
      • 6.3.2.3.1. Smart Textile
      • 6.3.2.3.2. Wearable Patch
      • 6.3.2.3.3. Others
    • 6.3.3. Connected Drug Delivery Systems
      • 6.3.3.1. Auto-injectors
      • 6.3.3.2. Inhalers
  • 6.4. E-Prescription

7. Connected Healthcare Market, By Applications

  • 7.1. Introduction
  • 7.2. Monitoring Applications
  • 7.3. Diagnosis & Treatment
  • 7.4. Education & Awareness
  • 7.5. Healthcare Management
  • 7.6. Wellness & Prevention
  • 7.7. Other Applications

8. Connected Healthcare Market, By Regions

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. U.S.
    • 8.2.3. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Germany
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Italy
    • 8.3.6. Spain
  • 8.4. Asia-Pacific
    • 8.4.1. Introduction
    • 8.4.2. Japan
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Australia
    • 8.4.6. Republic of Korea
  • 8.5. Middle East & Africa
    • 8.5.1. Introduction
    • 8.5.2. Africa
    • 8.5.3. Middle East

9. Competitive Landscape

  • 9.1. Introduction
    • 9.1.1. Partnerships, Agreements and Collaborations
    • 9.1.2. Product Development and Launch
    • 9.1.3. Approvals
    • 9.1.4. Acquisitions
    • 9.1.5. Award & Recognition
    • 9.1.6. Others

10. Company Profile

  • 10.1. Agamatrix, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Product/Business Segment Overview
    • 10.1.3. Financial Overview
    • 10.1.4. Key Development
    • 10.1.5. SWOT Analysis
  • 10.2. AirStrip Technologies
    • 10.2.1. Company Overview
    • 10.2.2. Product/Business Segment Overview
    • 10.2.3. Financial Overview
    • 10.2.4. Key Development
    • 10.2.5. SWOT Analysis
  • 10.3. AliveCor Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Product/Business Segment Overview
    • 10.3.3. Financial Overview
    • 10.3.4. Key Development
    • 10.3.5. SWOT Analysis
  • 10.4. Allscripts
    • 10.4.1. Company Overview
    • 10.4.2. Product/Business Segment Overview
    • 10.4.3. Financial Overview
    • 10.4.4. Key Development
    • 10.4.5. SWOT Analysis
  • 10.5. Apple Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Product/Business Segment Overview
    • 10.5.3. Financial Overview
    • 10.5.4. SWOT Analysis
  • 10.6. Athenahealth, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Product/Business Segment Overview
    • 10.6.3. Financial Overview
    • 10.6.4. Key Development
    • 10.6.5. SWOT Analysis
  • 10.7. Boston Scientific Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Product/Business Segment Overview
    • 10.7.3. Financial Overview
    • 10.7.4. Key Development
    • 10.7.5. SWOT Analysis
  • 10.8. Cerner
    • 10.8.1. Company Overview
    • 10.8.2. Product/Business Segment Overview
    • 10.8.3. Financial Overview
    • 10.8.4. Key Development
    • 10.8.5. SWOT Analysis
  • 10.9. GE Healthcare
    • 10.9.1. Company Overview
    • 10.9.2. Product/Business Segment Overview
    • 10.9.3. Financial Overview
    • 10.9.4. Key Development
    • 10.9.5. SWOT Analysis
  • 10.10. Honeywell Life Care Solutions
    • 10.10.1. Company Overview
    • 10.10.2. Product/Business Segment Overview
    • 10.10.3. Financial Overview
    • 10.10.4. Key Development
    • 10.10.5. SWOT Analysis
  • 10.11. Medtronics
    • 10.11.1. Company Overview
    • 10.11.2. Product/Business Segment Overview
    • 10.11.3. Financial Overview
    • 10.11.4. Key Development
    • 10.11.5. SWOT Analysis
  • 10.12. Microsoft
    • 10.12.1. Company Overview
    • 10.12.2. Product/Business Segment Overview
    • 10.12.3. Financial Overview
    • 10.12.4. SWOT Analysis
  • 10.13. Persistent Systems
    • 10.13.1. Company Overview
    • 10.13.2. Product/Business Segment Overview
    • 10.13.3. Financial Overview
    • 10.13.4. Key Development
    • 10.13.5. SWOT Analysis
  • 10.14. Koninklijke Philips N.V.
    • 10.14.1. Company Overview
    • 10.14.2. Product/Business Segment Overview
    • 10.14.3. Financial Overview
    • 10.14.4. Key Development
    • 10.14.5. SWOT Analysis
  • 10.15. Qualcomm
    • 10.15.1. Company Overview
    • 10.15.2. Product/Business Segment Overview
    • 10.15.3. Financial Overview
    • 10.15.4. Key Development
    • 10.15.5. SWOT Analysis
  • 10.16. Sanofi
    • 10.16.1. Company Overview
    • 10.16.2. Product/Business Segment Overview
    • 10.16.3. Financial Overview
    • 10.16.4. Key Development
    • 10.16.5. SWOT Analysis
  • 10.17. Vivify Health, Inc.
    • 10.17.1. Company Overview
    • 10.17.2. Product/Business Segment Overview
    • 10.17.3. Financial Overview
    • 10.17.4. SWOT Analysis

11. Appendix

List of Tables

  • TABLE 1: GLOBAL CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 2: M-HEALTH SERVICES MARKET, BY REGION, 2013-2022 (USD MILLION)
  • TABLE 3: M-HEALTH DEVICES MARKET, BY REGION, 2013-2022 (USD MILLION)
  • TABLE 4: MEDICAL DEVICES MARKET, BY REGION, 2013-2022 (USD MILLION)
  • TABLE 5: WEARABLE DEVICES MARKET, BY REGION, 2013-2022 (USD MILLION)
  • TABLE 6: CONNECTED DRUG DELIVERY SYSTEMS MARKET, BY REGION, 2013- 2022 (USD MILLION)
  • TABLE 7: E-PRESCRIPTION MARKET, BY REGION, 2013-2022 (USD MILLION)
  • TABLE 8: GLOBAL CONNECTED HEALTHCARE MARKET VALUE, BY APPLICATION, 2013-2022 (USDMILLION)
  • TABLE 9: MONITORING APPLICATIONS MARKET, BY REGION, 2013-2022 (USDMILLION)
  • TABLE 10: DIAGNOSIS & TREATMENTS MARKET, BY REGION, 2013-2022 (USDMILLION)
  • TABLE 11: EDUCATION & AWARENESSS MARKET, BY REGION, 2013-2022 (USD MILLION)
  • TABLE 12: HEALTHCARE MANAGEMENTS MARKET, BY REGION, 2013-2022 (USD MILLION)
  • TABLE 13: WELLNESS & PREVENTIONS MARKET, BY REGION, 2013-2022 (USDMILLION)
  • TABLE 14: OTHER APPLICATIONS: GLOBAL CONNECTED HEALTHCARE MARKET VALUE, BY GEOGRAPHY, 2014-2022 (USDMILLION)
  • TABLE 15: GLOBAL CONNECTED HEALTHCARE MARKET, BY REGION, 2013-2022 (USD MILLION)
  • TABLE 16: NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2013-2022 (USD MILLION)
  • TABLE 17: NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY TYPE, 2013- 2022 (USD MILLION)
  • TABLE 18: NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 19: NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 20: U.S. CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 21: U.S. CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 22: CANADA CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 23: CANADA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013- 2022 (USD MILLION)
  • TABLE 24: EUROPE CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2013- 2022 (USD MILLION)
  • TABLE 25: EUROPE CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 26: EUROPE CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013- 2022 (USD MILLION)
  • TABLE 27: GERMANY CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 28: GERMANY CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013- 2022 (USD MILLION)
  • TABLE 29: FRANCE CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 30: FRANCE CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 31: U.K. CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 32: U.K. CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 33: ITALY CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 34: ITALY CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 35: SPAIN CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 36: SPAIN CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 37: ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2013-2022 (USD MILLION)
  • TABLE 38: ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 39: ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 40: JAPAN CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 41: JAPAN CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013- 2022 (USD MILLION)
  • TABLE 42: CHINA CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 43: CHINA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 44: INDIA CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 45: INDIA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 46: AUSTRALIA CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 47: AUSTRALIA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 48: REPUBLIC OF KOREA CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 49: REPUBLIC OF KOREA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 50: MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY REGION, 2013-2022 (USD MILLION)
  • TABLE 51: MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY TYPE, 2013-2022 (USD MILLION)
  • TABLE 52: MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2013-2022 (USD MILLION)
  • TABLE 53: CONNECTED HEALTHCARE: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
  • TABLE 54: CONNECTED HEALTHCARE: PRODUCT DEVELOPMENT AND LAUNCH
  • TABLE 55: CONNECTED HEALTHCARE: APPROVALS
  • TABLE 56: CONNECTED HEALTHCARE: ACQUISITIONS
  • TABLE 57: CONNECTED HEALTHCARE: AWARD & RECOGNITION
  • TABLE 58: CONNECTED HEALTHCARE: OTHERS
  • TABLE 59: AGAMATRIX, INC.: KEY DEVELOPMENT
  • TABLE 60: AIRSTRIP TECHNOLOGIES: KEY DEVELOPMENT
  • TABLE 61: ALIVECOR INC.: KEY DEVELOPMENT
  • TABLE 62: ALLSCRIPTS: KEY DEVELOPMENT
  • TABLE 63: ATHENAHEALTH, INC.: KEY DEVELOPMENT
  • TABLE 64: BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENT
  • TABLE 65: CERNER: KEY DEVELOPMENT
  • TABLE 66: GE HEALTHCARE: KEY DEVELOPMENT
  • TABLE 67: HONEYWELL LIFE CARE SOLUTIONS: KEY DEVELOPMENT
  • TABLE 68: MEDTRONICS: KEY DEVELOPMENT
  • TABLE 69: PERSISTENT SYSTEMS: KEY DEVELOPMENT
  • TABLE 70: KONINKLIJKE PHILIPS N.V.: KEY DEVELOPMENT
  • TABLE 71: QUALCOMM: KEY DEVELOPMENT
  • TABLE 72: SANOFI: KEY DEVELOPMENT

List of Figures

  • FIGURE 1: GLOBAL CONNECTED HEALTHCARE: MARKET STRUCTURE
  • FIGURE 2: RESEARCH PROCESS OF MRFR
  • FIGURE 3: GLOBAL CONNECTED HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 4: GLOBAL CONNECTED HEALTHCARE MARKET: PORTER FIVE FORCES ANALYSIS
  • FIGURE 5: GLOBAL CONNECTED HEALTHCARE MARKET: VALUE CHAIN
  • FIGURE 6: GLOBAL CONNECTED HEALTHCARE MARKET, BY TYPE, 2015 (%)
  • FIGURE 7: M-HEALTH SERVICES MARKET, BY REGION, 2015 & 2022 (USD MILLION)
  • FIGURE 8: TYPES OF CONNECTED HEALTHCARE SERVICES
  • FIGURE 9: M-HEALTH DEVICES MARKET, BY REGION, 2015 & 2022 (USD MILLION)
  • FIGURE 10: TYPE OF CONNECTED HEALTHCARE DEVICES
  • FIGURE 11: TYPES OF WEARABLE DEVICES
  • FIGURE 12: E-PRESCRIPTION MARKET, BY REGION, 2015 & 2022 (USD MILLION)
  • FIGURE 13: TYPES OF CONNECTED HEALTHCARE APPLICATION
  • FIGURE 14: GLOBAL CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2015 & 2022 (USD MILLION)
  • FIGURE 15: GLOBAL CONNECTED HEALTHCARE MARKET SHARE, BY REGIONS
  • FIGURE 16: GLOBAL CONNECTED HEALTHCARE MARKET, BY REGION, 2015 & 2022 (USD MILLION)
  • FIGURE 17: NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2015 (%)
  • FIGURE 18: NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY TYPE, 2015 & 2022 (USD MILLION)
  • FIGURE 19: EUROPE CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2015 (%)
  • FIGURE 20: EUROPE CONNECTED HEALTHCARE MARKET, BY TYPE, 2015 & 2022 (USD MILLION)
  • FIGURE 21: EUROPE CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2015 & 2022 (USD MILLION)
  • FIGURE 22: ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2015 (%)
  • FIGURE 23: ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY TYPE, 2015 & 2022 (USD MILLION)
  • FIGURE 24: ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2015 & 2022 (USD MILLION)
  • FIGURE 25: MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2015 (%)
  • FIGURE 26: MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY TYPE, 2015 & 2022 (USD MILLION)
  • FIGURE 27: MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2015 & 2022 (USD MILLION)
  • FIGURE 28: COMPETITIVE ANALYSIS
  • FIGURE 29: AGAMATRIX, INC.: SWOT ANALYSIS
  • FIGURE 30: AIRSTRIP TECHNOLOGIES: SWOT ANALYSIS
  • FIGURE 31: ALIVECOR INC.: SWOT ANALYSIS
  • FIGURE 32: ALLSCRIPTS: RECENT FINANCIAL
  • FIGURE 33: ALLSCRIPTS: OPERATING SEGMENTS
  • FIGURE 34: ALLSCRIPTS: GEOGRAPHIC REVENUE MIX
  • FIGURE 35: ALLSCRIPTS: SWOT ANALYSIS
  • FIGURE 36: APPLE INC.: RECENT FINANCIAL
  • FIGURE 37: APPLE INC.: OPERATING SEGMENTS
  • FIGURE 38: APPLE INC.: GEOGRAPHIC REVENUE MIX
  • FIGURE 39: APPLE INC.: SWOT ANALYSIS
  • FIGURE 40: ATHENAHEALTH, INC.: RECENT FINANCIAL
  • FIGURE 41: ATHENAHEALTH, INC.: SWOT ANALYSIS
  • FIGURE 42: BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL
  • FIGURE 43: BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL
  • FIGURE 44: BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
  • FIGURE 45: CERNER: RECENT FINANCIAL
  • FIGURE 46: CERNER: GEOGRAPHICAL MIX
  • FIGURE 47: CERNER: SWOT ANALYSIS
  • FIGURE 48: GE HEALTHCARE: RECENT FINANCIAL
  • FIGURE 49: GE HEALTHCARE: OPERATING SEGMENTS
  • FIGURE 50: GE HEALTHCARE: GEOGRAPHICAL MIX
  • FIGURE 51: GE HEALTHCARE: SWOT ANALYSIS
  • FIGURE 52: HONEYWELL LIFE CARE SOLUTIONS: RECENT FINANCIAL
  • FIGURE 53: HONEYWELL LIFE CARE SOLUTIONS: OPERATING SEGMENTS
  • FIGURE 54: HONEYWELL LIFE CARE SOLUTIONS: GEOGRAPHICAL MIX
  • FIGURE 55: HONEYWELL LIFE CARE SOLUTIONS: SWOT ANALYSIS
  • FIGURE 56: MEDTRONICS: RECENT FINANCIAL
  • FIGURE 57: MEDTRONICS: OPERATING SEGMENTS
  • FIGURE 58: MEDTRONICS: GEOGRAPHICAL MIX
  • FIGURE 59: MEDTRONICS: SWOT ANALYSIS
  • FIGURE 60: MICROSOFT: RECENT FINANCIAL
  • FIGURE 61: MICROSOFT: OPERATING SEGMENTS
  • FIGURE 62: MICROSOFT: GEOGRAPHICAL MIX
  • FIGURE 63: MICROSOFT: SWOT ANALYSIS
  • FIGURE 64: PERSISTENT SYSTEMS: RECENT FINANCIAL
  • FIGURE 65: PERSISTENT SYSTEMS: GEOGRAPHICAL MIX
  • FIGURE 66: PERSISTENT SYSTEMS: SWOT ANALYSIS
  • FIGURE 67: KONINKLIJKE PHILIPS N.V.: RECENT FINANCIAL
  • FIGURE 68: KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
  • FIGURE 69: KONINKLIJKE PHILIPS N.V.: GEOGRAPHICAL MIX
  • FIGURE 70: KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS
  • FIGURE 71: QUALCOMM: RECENT FINANCIAL
  • FIGURE 72: QUALCOMM: GEOGRAPHICAL MIX
  • FIGURE 73: QUALCOMM: SWOT ANALYSIS
  • FIGURE 74: SANOFI: RECENT FINANCIAL
  • FIGURE 75: SANOFI: OPERATING SEGMENTS
  • FIGURE 76: SANOFI: GEOGRAPHICAL MIX
  • FIGURE 77: SANOFI: SWOT ANALYSIS
  • FIGURE 78: VIVIFY HEALTH, INC.: SWOT ANALYSIS
Back to Top
전화 문의
F A Q